Th2 infiltration is a better predictor of survival than tumor-infiltrating lymphocytes (TILs) in triple-negative breast cancer (TNBC)
Preprint in medRxiv (June 2023)
The most recent citing publications are shown below. View all 43 publications that cite this research output on Dimensions.
Preprint in medRxiv (June 2023)
Article in Clinical and Translational Oncology (January 2023)
Article in Archivum Immunologiae et Therapiae Experimentalis (June 2021)